Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Parabilis Medicines, Inc.
Novartis
Neonc Technologies, Inc.
Roswell Park Cancer Institute
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Hospital of Macerata
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Toray Industries, Inc
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Shanghai Junshi Bioscience Co., Ltd.